Plasma exchange for myeloma kidney: cast(s) away?
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 18480853.
- Also identified by DOI 10.1038/ki.2008.117.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Leung et al. (this issue) present a retrospective study of 40 patients. Observations in 14/40 led to the suggestion of restitution of plasma exchange for light-chain responsive, biopsy-proven myeloma kidney until a better randomized control trial (RCT) is constructed. A careful analysis of their study and a recent RCT suggest little difference in outcome between plasma exchange and control groups. The analysis supports restitution of a better RCT of plasma exchange for myeloma kidney rather than off-label use.
Medical subject headings
- Kidney Neoplasms
- Multiple Myeloma
- Plasma Exchange